SOCS2
Spezies: Human
Wirt: Tobacco (Nicotiana tabacum)
Recombinant
>80 % as determined by SDS PAGE, Size Exclusion Chromatography and Western Blot.
WB, SDS, ELISA
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
50 mM Tris-HCI, 10 mM reduced Glutathione, pH =8.0 in the elution buffer.
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-80 °C
Informationen zur Lagerung
Best use within three months from the date of receipt of this protein.
Sen, Peng, Woods, Wistuba, Bell, El-Naggar, Lai, Johnson: "STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 1, pp. 127-39, (2012) (PubMed).
Target
SOCS2
(Suppressor of Cytokine Signaling 2 (SOCS2))